- Using Circulating Tumor DNA (ctDNA) As Screening and Predictive Marker in Cervical Carcinoma Patients Receiving Radiation TherapyYang, J. L.; Fan, M.; Chen, M. H.; Pan, L.; Ma, J.; Lang, J.60th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), San Antonio, TX, 2018-10-21 To 2018-10-24.
- Revealing differences in radiosensitivity of advanced non-small cell lung cancer (NSCLC)through single-cell sequencing dataYou, P.; Zhou, H.; Li, Q.; Xie, D.; Yao, L.; Liu, S.Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), Barcelona, SPAIN, 2023-10-20 To 2023-10-24.
- Detection of circulating tumor DNA by digital droplet PCR in resectable lung cancer as a predictive tool for recurrenceGassa Asmae; Fassunke Jana; Schuetten Sarah; Kuhlmann Luca; Scherer Marie; Sun Jie; Zhao Yue; Michel Max; Loeser Heike; Wolf Juergen; Buettner Reinhard; Doerr Fabian; Heldwein Matthias; Hagmeyer Lars; Frank Konrad; Merkelbach Bruse Sabine; Quaas Alexander; Bruns Christiane J.; Alakus HakanLung Cancer, 2020, prepublish.
会议论文
Analysis of Circulating Tumor DNA Kinetics during Stereotactic Ablative Radiation Therapy for Non-Small Cell Lung Cancer
9阅读
